. CPP measured at the same times was 23 ± 7, 20 ± 7, and 23 ± 7 mmHg in group A; and 13 ± 7, 6 ± 5, and 6 ± 7 mmHg in group B (P=0.01, <0.001, and <0.001). Conclusion. The study showed that a single dose of terlipressin, when added to adrenaline, was effective for achievement of higher vital organ perfusion pressures compared to adrenaline alone.
Introduction
Cardiac arrest leads to rapid development of intense global myocardial ischemia, especially when ventricular fibrillation (VF) is the precipitating mechanism. (1) It is known that successful resuscitation relies on capability for generating coronary blood flow above critical threshold levels. ( 2) The achieved coronary perfusion pressure (CorPP) during cardiopulmonary resuscitation (CPR) predicts the probability of successful defibrillation and return of spontaneous circulation (ROSC), while cerebral perfusion pressure (CPP) determines the extent of ischaemic brain injury. (2, 3) In order to increase vital organ perfusion pressures, vasopressor agents have been used since the early 1960s. (4) Both European Resuscitation Council (ERC) and American Heart Association (AHA) Guidelines recommend administration of adrenaline (epinephrine), although there is no evidence proving that its use in humans increases survival to hospital discharge. (5, 6) It is important to find more effective treatment since the vital organ perfusion induced by chest compressions is not only critical but essential for survival. (6) The non-adrenergic vasopressor, vasopressin (8-arginine vasopressin), has been the most promising alternative so-far studied, (7-10) but it is not routinely available in Europe. (11) Recent data show that use of terlipressin (triglycyl -lysine vasopressin), a vasopressin synthetic analogue, may also have a favourable effect in treatment of cardiac arrest caused by toxins, anaphylaxis, and in children. (12) (13) (14) (15) (16) (17) Although terlipressin is known to be a strong vasoconstrictor, (18) its possible role in treatment of VF, the most frequent cause of cardiac arrest in adults, remains unknown. Our study was designed to compare the effect on vital organ perfusion pressures of adjunct terlipressin with that of placebo when the drug was added to repeated doses of adrenaline. We expected that early addition of a synergically acting vasopressor would increase CorPP and CPP during prolonged CPR in a porcine model of VF with realistic time intervals to drug delivery derived from data on the outof-hospital setting.
Material and methods
This was a prospective, randomized, blinded, placebo-controlled experimental study in fourteen healthy, 15 
Measurements
After induction of anaesthesia, the thoracic aorta was cannulated via the caro- Table 2 . Arterial blood gases (ABG) analysis in both study groups (A = terlipressin; B = placebo). ABG were taken at the time (T) of -1 min (pre-arrest baseline values), +15 min (after 5 min of untreated VF and 10 min lasting period of chest compressions without ventilation), +30 min, and +45 min (after 15 min, and 30 min of ALS respectively); values are displayed as mean ± S.D.
ALS, advanced life support; BE, arterial base excess; BLS, basic life support (compressiononly CPR); FiO 2 , fraction of inspired oxygen; PaCO 2 , arterial carbon dioxide partial pressure; PaO 2 , arterial oxygen partial pressure; SaO 2 , arterial oxygen saturation. ANOVA was used to determine statistical significance within groups (* P < 0.05, † P < 0.01, ‡ P < 0.001 vs. T=+15 before drug administration), and between groups (# P < 0.05).
Time 
-(ICP + CVP). (20)
The preparation phase, including all surgical procedures and instrumentation, was followed with a period of animal stabilisation lasting 45 min. Arterial blood gases (ABG) were obtained every 15 min to analyse pH, partial pressures of oxygen and carbon dioxide (PaO 2 and PaCO 2 ), oxygen saturation (SaO 2 ) and base excess (BE). ABG were measured with a blood-gas analyser AVL Omni 6 (Roche Diagnostics GmbH, Graz, Austria) and corrected to body temperature.
Experimental Protocol
The time line of the study protocol is presented in figure 1 . Five minutes before induction of VF (T=-5), all anaesthetic drugs were withdrawn, fraction of inspired oxygen (FiO 2 ) was decreased to 0.21 and heparin (5000 IU) was given to prevent intra-cardiac clot formation. Baseline (BL) haemodynamic variables and ICP were recorded. VF was induced with an alternating current of 5-10 V using 5F intra-cardiac bipolar pacing lead VascoStim (Arrow Int. Europe, Tongeren, Belgium) introduced via the Intro-Flex sheath into the right ventricle. Circulatory arrest (T=0) was defined as that point at which both systolic and diastolic aortic pressures dropped down to equal values and the ECG showed VF. At that time, artificial ventilation was stopped. After 5 minutes of untreated cardiac arrest (T=+5), mechanical chest compressions without ventilation were started using the AutoPulse. Its backboard contains a motor to retract a load-distributing band (LDB) which adjusts lengthwise to the size of the thorax. The microprocessor is programmed to provide a constant 20% reduction in the anterior-posterior dimension of the individual chest during compressions at a rate of 80·min -1 . (21) At the time of 15 minutes after onset of VF (T=+15), non-synchronized mechanical ventilation (FiO 2 =1.0, V T 8 mL·kg -1 ) at a rate of 10 breaths per minute was started and continued for 45 minutes. The AutoPulse-generated chest compressions were then paused every 5 minutes for 10 seconds (for rhythm analysis and to check for pulse). The pigs were randomly assigned into 2 groups to receive either terlipressin (group A: n = 7) or placebo (group B: n = 7) together with the first dose of adrenaline. The randomization scheme was generated from the website 'Randomization.com' (available at http://www. randomization.com) using a method of randomly permutated blocks with a size of 6 and 8. All investigators involved in the study were blinded to both the randomization scheme and the drugs, which were diluted in isotonic saline and distributed in numbered 10 mL syringes by someone not involved in the trial. The randomization plan was not available to the staff before statistical analysis was completed. The first drug was given in both groups 19 min after induction of VF (T=+19 
Statistical Analysis
Statistics were performed using commercial software Statistica 9.0 (StatSoft Inc., Tulsa, OK, USA). The tested null hypothesis was that adjunct terlipressin would not change CorPP and CPP compared to placebo given in treatment of VF. A Kolmogorov-Smirnov test was used to verify Gaussian distribution. Data were analyzed using a two-way repeated measures analysis of variance (ANOVA) factoring for time and treatment effects. Fisher´s protected least significant difference (LSD) was used for post hoc testing to identify the differences. The baseline data and time intervals were analyzed with a two-sample t-test for continuous variables. Comparisons of proportions were analyzed with a Fisher´s exact test. All data are expressed as mean ± standard deviation (S.D.). Statistical significance was considered at P-value < 0.05.
Results
There were no differences in pre-arrest baseline characteristics between groups (table 1) . At the end of the basic life support (BLS) period, there were also no significant differences in received medication, intracerebral, arterial or venous pressures, or ABG analysis between groups. The mean responses of CorPP and CPP were different for terlipressin and placebo (P = 0.018, and 0.003 respectively). CorPP increased immediately after vasopressors were given, but remained higher in group A compared to group B until the end of the experiment. CorPP (mean ± S.D.) measured 35, 45, and 55 min after the onset of VF was 12 ± 4, 11 ± 6, and 10 ± 5 mmHg in the terlipressin group A; and 6 ± 4, 1 ± 5, and -1 ± 5 mmHg in the placebo group B (P = 0.03, < 0.001, and < 0.001 respectively). Adrenaline with added terlipressin was able to maintain CorPP above critical threshold level of 10 mmHg for longer compared to adrenaline alone: 27.9 ± 11.0 vs. 10.1 ± 5.8 min (P = 0.003). At a time of 20 min after the first drug administration, terlipressin maintained CorPP > 10 mmHg in 6 out of 7 animals (85.7%) compared to none in group B (P = 0.005) (figure 2). CPP at time 35, 45, and 55 min was 23 ± 7, 20 ± 7, and 23 ± 7 mmHg in group A; and 13 ± 7, 6 ± 5, and 6 ± 7 mmHg in group B (P = 0.01, < 0.001, and < 0.001 respectively). CPP was significantly higher in group A compared to placebo group B, and was maintained above the level of 20 mmHg until the late period of CPR (figure 2). Pre-arrest ABG analysis showed no statistical differences between study groups. The pH was less than 7.2 after no-CPR and compression-only CPR periods, and increased in both groups after ALS was initiated (P = 0.01 and P = 0.02 for T=+30 versus T=+15). There were no differences in pH between groups at T=+30 and T=+45 (7.30 vs. 7.24, P = 0.26, and 7.25 vs. 7.25, P = 0.92 respectively). In pigs treated with terlipressin, there was higher PaO 2 measured 10 min after administration of the drug when compared to animals treated with adrenaline alone (341 vs. 238 mmHg, P = 0.03) (table 2) . ROSC was not achieved in any pig. In all animals, VF converted into asystole before termination of the experiment. However, VF lasted 47.4 ± 8.9 min in group A but only 40.3 ± 11.4 min in group B with lower coronary perfusion (P = 0.22). Autopsy confirmed correct positioning of all catheters and revealed minor injuries in 2 of 14 animals after 45 min of mechanical CPR (2x rib fractures; 1x haemothorax < 100 mL).
Discussion
In our time-realistic model of ventricular fibrillation, adjunct terlipressin added to the first dose of repeated adrenaline increased both CorPP and CPP, and maintained perfusion pressures higher until the very end of prolonged 60 min duration cardiac arrest. Current Guidelines recommend continuation of CPR until VF is present, but maintaining blood pressure over a prolonged period may be difficult. (5) Some ambulance services also transport their patients to hospital with ongoing CPR. (5, 22) This approach increases demands on maintaining sufficient blood pressure for a longer time. There is a strong relationship between CorPP and initial resuscitation rates. (2) Different critical threshold levels for CorPP predictive of outcome have been identified in various cardiac arrest models, corresponding to 20 mm Hg in dogs, 15 mm Hg in humans, and 10 mm Hg in pigs. (2, 23, 24) In order to increase CorPP above these resuscitability thresholds, administration of exogenous vasopressors is often necessary.
Adrenaline is routinely used in the treatment of cardiac arrest. However, there is no evidence that adrenaline improves long-term survival in humans. (5, 6, 25, 26) The failure of many experimental studies to translate their results into clinical practice was caused by their inappropriate design that did not reflect realistic conditions. (27,28) Based on available literature, the mean time to first drug administration was only 9.5 min in experiments while in the out-ofhospital setting, the first drug is usually given 19.4 minutes after suspected onset of VF. (27) Thus, the flowchart of our study was designed to respect realistic timing of OHCA. (27) 
Conclusion
The study showed that a single-dose of terlipressin -when added early to adrenaline in a time-realistic animal model of ventricular fibrillation -is effective for maintaining higher vital organ perfusion pressures until the very late phase of CPR while adrenaline alone was unable to prevent severe refractory hypotension.
